|
BFAR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.04109999802205E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.75379999914449E-08 |
| Normal-vs-Stage2 |
4.258200E-02 |
| Normal-vs-Stage3 |
3.432700E-04 |
| Normal-vs-Stage4 |
1.58029999999254E-05 |
| Stage1-vs-Stage2 |
8.374400E-02 |
| Stage1-vs-Stage3 |
1.326430E-01 |
| Stage1-vs-Stage4 |
7.438800E-01 |
| Stage2-vs-Stage3 |
5.111600E-01 |
| Stage2-vs-Stage4 |
7.638200E-02 |
| Stage3-vs-Stage4 |
1.341970E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.03910000288133E-08 |
| Normal-vs-AfricanAmerican |
1.000310E-03 |
| Normal-vs-Asian |
2.979900E-04 |
| Caucasian-vs-AfricanAmerican |
9.826600E-01 |
| Caucasian-vs-Asian |
8.889000E-01 |
| AfricanAmerican-vs-Asian |
9.071600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32340000069675E-08 |
| Normal-vs-Female |
1.22820000003632E-06 |
| Male-vs-Female |
4.482000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.06750000137413E-09 |
| Normal-vs-Age(41-60Yrs) |
5.68979999999719E-05 |
| Normal-vs-Age(61-80Yrs) |
6.563500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.633700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.353500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.053600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.046600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.224600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.029200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.744800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.570200E-01 |
| Classical-VS-Follicular |
8.035400E-04 |
| Classical-VS-Other |
4.545800E-01 |
| Classical-VS-Normal |
1.03870001488815E-09 |
| Tall-VS-Follicular |
1.052580E-01 |
| Tall-VS-Other |
3.243000E-01 |
| Tall-VS-Normal |
6.623000E-04 |
| Follicular-VS-Other |
4.334300E-02 |
| Follicular-VS-Normal |
8.270300E-02 |
| Other-VS-Normal |
7.470200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.37379999999244E-05 |
| Normal-vs-N1 |
7.94270000000763E-05 |
| N0-vs-N1 |
3.392600E-01 |
|
|
